FR2883171B1 - Utilisation d'agents tels que des donneurs ou liberateurs non polymeriques de monoxyde d'azote pour diminuer les poches et/ou les cernes perioculaires - Google Patents

Utilisation d'agents tels que des donneurs ou liberateurs non polymeriques de monoxyde d'azote pour diminuer les poches et/ou les cernes perioculaires

Info

Publication number
FR2883171B1
FR2883171B1 FR0550657A FR0550657A FR2883171B1 FR 2883171 B1 FR2883171 B1 FR 2883171B1 FR 0550657 A FR0550657 A FR 0550657A FR 0550657 A FR0550657 A FR 0550657A FR 2883171 B1 FR2883171 B1 FR 2883171B1
Authority
FR
France
Prior art keywords
cernes
liberators
periocular
pockets
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0550657A
Other languages
English (en)
Other versions
FR2883171A1 (fr
Inventor
Grierson Marie Madeleine Cals
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0550657A priority Critical patent/FR2883171B1/fr
Publication of FR2883171A1 publication Critical patent/FR2883171A1/fr
Application granted granted Critical
Publication of FR2883171B1 publication Critical patent/FR2883171B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/0229—Sticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
FR0550657A 2005-03-15 2005-03-15 Utilisation d'agents tels que des donneurs ou liberateurs non polymeriques de monoxyde d'azote pour diminuer les poches et/ou les cernes perioculaires Expired - Fee Related FR2883171B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0550657A FR2883171B1 (fr) 2005-03-15 2005-03-15 Utilisation d'agents tels que des donneurs ou liberateurs non polymeriques de monoxyde d'azote pour diminuer les poches et/ou les cernes perioculaires

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0550657A FR2883171B1 (fr) 2005-03-15 2005-03-15 Utilisation d'agents tels que des donneurs ou liberateurs non polymeriques de monoxyde d'azote pour diminuer les poches et/ou les cernes perioculaires

Publications (2)

Publication Number Publication Date
FR2883171A1 FR2883171A1 (fr) 2006-09-22
FR2883171B1 true FR2883171B1 (fr) 2007-05-11

Family

ID=35240993

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0550657A Expired - Fee Related FR2883171B1 (fr) 2005-03-15 2005-03-15 Utilisation d'agents tels que des donneurs ou liberateurs non polymeriques de monoxyde d'azote pour diminuer les poches et/ou les cernes perioculaires

Country Status (1)

Country Link
FR (1) FR2883171B1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
US11110049B2 (en) 2017-06-23 2021-09-07 The Procter & Gamble Company Composition and method for improving the appearance of skin
US11583488B2 (en) 2020-06-01 2023-02-21 The Procter & Gamble Company Method of improving penetration of a vitamin B3 compound into skin
US11622963B2 (en) 2018-07-03 2023-04-11 The Procter & Gamble Company Method of treating a skin condition

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926021B1 (fr) * 2008-01-03 2012-12-14 Oreal Utilisation de derives c-glycoside a titre d'actif vasculaire
FR2977252B1 (fr) * 2011-06-30 2013-08-02 Seppic Sa Nouveaux esters de derives n-acyles d'acides amines et d'isosorbide, procede pour leur preparation, et utilisation en cosmetique et comme medicament.
FR2981932B1 (fr) 2011-10-27 2014-10-31 Seppic Sa Nouveaux esters de derives n-acyles d'acides amines et de diols, procede pour leur preparation, et utilisation en cosmetique et comme medicament
CA2896348C (fr) * 2013-01-28 2020-12-08 Unilever Plc Compositions pour soins de la peau comprenant de l'acide folique et de la catechine de gallate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0232006A (ja) * 1988-07-21 1990-02-01 Shiseido Co Ltd 皮膚外用剤
FR2679141B1 (fr) * 1991-07-19 1994-02-25 Lvmh Recherche Composition cosmetique ou pharmaceutique, notamment dermatologique, destinee en particulier a favoriser la pigmentation de la peau ou des cheveux, contenant un extrait de marrubium vulgare, et son procede de fabrication.
FR2753378B1 (fr) * 1996-09-17 1998-11-20 Oreal Utilisation dans une composition en tant que stimulateur de tyrosinase d'au moins un derive de pyrimidine 3-oxyde, substitue en 6
FR2767692B1 (fr) * 1997-09-01 2000-03-03 Oreal Utilisation d'une substance agoniste d'un recepteur associe a un canal chlore ou potassique dans le traitement des peaux sensibles
US6265412B1 (en) * 1998-05-26 2001-07-24 Taisho Pharmaceutical Co., Ltd. Minoxidil compositions for external use
JP4229842B2 (ja) * 2002-02-22 2009-02-25 ルバンス セラピュティックス インク． Ｌ−アルギニンオリゴマーを含む化粧品処方

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11110049B2 (en) 2017-06-23 2021-09-07 The Procter & Gamble Company Composition and method for improving the appearance of skin
US11622963B2 (en) 2018-07-03 2023-04-11 The Procter & Gamble Company Method of treating a skin condition
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
US11583488B2 (en) 2020-06-01 2023-02-21 The Procter & Gamble Company Method of improving penetration of a vitamin B3 compound into skin
US11911498B2 (en) 2020-06-01 2024-02-27 The Procter & Gamble Company Low pH skin care composition and methods of using the same

Also Published As

Publication number Publication date
FR2883171A1 (fr) 2006-09-22

Similar Documents

Publication Publication Date Title
FR2883171B1 (fr) Utilisation d'agents tels que des donneurs ou liberateurs non polymeriques de monoxyde d'azote pour diminuer les poches et/ou les cernes perioculaires
MY172157A (en) Thioninium compounds and their use
FR2880802B1 (fr) Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene
FR2932397B1 (fr) Solide hybride cristallin poreux reductible pour la separation de melanges de molecules ayant des degres et/ou un nombre d'insaturations differents
EP2666472A3 (fr) Utilisations et compositions pour le traitement de l'arthrite psoriasique
GB2414933B (en) Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
TW200621745A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
MA28003A1 (fr) [1,8] naphtyridine-2-ones et composes apparentes pour le traitement de la schizophrenie
FR2889057B1 (fr) Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
CY1108409T1 (el) Υβριδικα αντιβιοτικα οξαζολιδινονης-κινολονης
FR2865130B1 (fr) Film anhydre pour le maquillage ou le soin des levres.
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
MA34067B1 (fr) Composés à base de complexes de fe(iii) pour le traitement et la prévention des carences en fer et des anémies dues à une carence en fer
MA30331B1 (fr) ANTICORPS à EFGL 7 ET LEURS PROCEDES D'UTILISATION
ATE445692T1 (de) Polydextrose induzierte zweiphasige zusammensetzung
FR2920076B1 (fr) Dispositif de conditionnement et d'application pour composition cosmetique
MA32572B1 (fr) Kit pour le traitement des onychomycoses
HK1125055A1 (en) Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia tpo
FR2905070B1 (fr) Composition cosmetique pour l'eclaicissement ou l'homogeneisation du teint
EP2017620A3 (fr) Diagnostics et thérapeutiques de maladies associées à la dipeptidyl-peptidase 1 (DPP1)
FR2919187B1 (fr) Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
FR2868252B1 (fr) Utilisation des ulvanes comme eliciteurs des mecanismes d'absorption de l'azote et de la synthese proteique
FR2883177B1 (fr) Utilisation d'agrnets tels que des donneurs ou liberateurs non polymeriques de monoxyde d'azote pour repulper et/ou colorer naturellement les levres
FR2962902B1 (fr) Utilisation cosmetique d'une eau de source et compositions cosmetiques ou dermatologiques la contenant
FR2903999B1 (fr) Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091130